ASCCP guidelines and breast imaging on the heels of COVID-19
We hear from Christine Isaacs, MD about the new ASCCP guidelines and what they mean for ob/gyns.
The new ASCCP guidelines expand recommendations for cervical cancer screening to include screening every 5 years with primary high-risk human papillomavirus (hrHPV) testing. If you missed Isaacs' presentation at the 2021 ACOG ACSM, “While You Were Slee(PPE)ing: Women’s Health Updates Beyond the Pandemic’s Priorities,” read a summary here.
The guidelines were released in 2020 and, in 2021, were endorsed by the American College of Obstetricians and Gynecologists (ACOG) and the Society of Gynecologic Oncology (SGO).
Rebecca B. Perkins, MD, MSC, also presented the guidelines at ACOG’s Annual Clinical and Scientific Meeting earlier this year.
Dostarlimab shows significant survival benefits in endometrial cancer trial
March 21st 2024GlaxoSmithKline's phase 3 trial demonstrated promising overall and progression-free survival outcomes in patients with primary advanced or recurrent endometrial cancer, paving the way for potential FDA approval.
Read More
Unifying radical hysterectomy classifications with the Querleu-Morrow
February 16th 2024Explore how the latest research underscores the efficacy of the 2017 Querleu-Morrow classification in defining radical hysterectomy extent, shedding light on surgical terminologies for cervical cancer management.
Read More
